Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$196 Mln
Revenue (TTM)
$1,845 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.9
Industry P/E
--
EV/EBITDA
-0.5
Div. Yield
0 %
Debt to Equity
1.1
Book Value
$1511.8
EPS
$-283.1
Face value
--
Shares outstanding
7,042,547
CFO
$820.34 Mln
EBITDA
$886.23 Mln
Net Profit
$874.92 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zepp Health - ADR
| -50.2 | -40.3 | -51.7 | 277.7 | 30.2 | -23.6 | -- |
|
BSE Sensex*
| -14.1 | -12.2 | -15.0 | -5.5 | 7.7 | 7.9 | 11.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zepp Health - ADR
| 936.2 | -53.9 | -2.1 | -70.3 | -57.4 | -1.4 | 22.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zepp Health - ADR
|
13.4 | 196.1 | 1,815.2 | -280.9 | -9.9 | -16.8 | -- | 0.9 |
| 45.8 | 11,329.2 | 6,708.0 | 373.9 | 7.8 | 8.7 | 30.5 | 2.5 | |
| 248.0 | 3,644,938.8 | 435,617.0 | 117,777.0 | 32.3 | 152.9 | 31.4 | 41.3 | |
| 136.6 | 7,038.5 | 30,852.9 | 571.3 | 2.7 | 9.3 | 12.5 | 1.1 | |
| 18.0 | 2,433.9 | 4.6 | -189.3 | -1,958.3 | 1048.1 | -- | 238.9 | |
| 7.9 | -- | 4.6 | -189.3 | -1,958.3 | 1048.1 | -- | 0.0 | |
| 200.2 | 9,948.9 | 1,005.3 | 136.8 | 15.2 | 6.8 | 72 | 4.7 | |
| 73.6 | 6,811.0 | 1,050.0 | -40.4 | 12.1 | -6.8 | -- | 12.4 | |
| 325.3 | 8,555.9 | 326.7 | -42.9 | -17.5 | -4.6 | -- | 7.4 | |
| 91.5 | 9,465.7 | 2,906.4 | 177.5 | 8.8 | 10.7 | 54.5 | 5.4 |
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp... Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, scales, and rings; and associated accessories, smart hearable products, sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands. Read more
Founder, Chairman & CEO
Mr. Wang Huang
Founder, Chairman & CEO
Mr. Wang Huang
Headquarters
Gorinchem
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Zepp Health Corporation - ADR is $13.41 (NYSE) as of 20-Mar-2026 16:00 EDT. Zepp Health Corporation - ADR has given a return of 30.17% in the last 3 years.
Since, TTM earnings of Zepp Health Corporation - ADR is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.10
|
0.02
|
|
2024
|
-1.09
|
0.33
|
|
2023
|
-0.10
|
0.01
|
|
2022
|
-0.08
|
0.01
|
|
2021
|
2.45
|
0.11
|
The 52-week high and low of Zepp Health Corporation - ADR are Rs 61.85 and Rs 2.13 as of 23-Mar-2026.
Zepp Health Corporation - ADR has a market capitalisation of $ 196 Mln as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Zepp Health Corporation - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.60
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.